You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《大行報告》高盛首予醫脈通(02192.HK)「中性」評級 目標價35元
阿思達克 08-17 09:57
高盛發表報告指,相信醫脈通(02192.HK)作為內地最大的在線專業醫生平台,在精準營銷解決方案近期崛起和智能病人管理需求的長遠增長下,料實現快速收入和淨利潤複合增長,並認為其專有技術、內容生成能力和其醫生社區平台應能從內地數字醫療營銷支出的長期增長中受益。 報告首予醫脈通「中性」評級,因看到中國境外醫療覆蓋範圍內其他獲「買入」評級的公司有更高的相對目標價隱含上升空間,當中上升空間中位數為46%。高盛對醫脈通目標價35元。 該行料醫脈通2021至2023年各年收入分別3.596億、6.422億及11.112億元人民幣,各年每股純利分別27分、32分及47分人民幣。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account